Bacteriophage therapy reduces Staphylococcus aureus in a porcine and human ex vivo burn wound infection model.
Ontology highlight
ABSTRACT: Burn wounds are a major burden, with high mortality rates due to infections. Staphylococcus aureus is a major causative agent of burn wound infections, which can be difficult to treat because of antibiotic resistance and biofilm formation. An alternative to antibiotics is the use of bacteriophages, viruses that infect and kill bacteria. We investigated the efficacy of bacteriophage therapy for burn wound infections, in both a porcine and a newly developed human ex vivo skin model. In both models, the efficacy of a reference antibiotic treatment (fusidic acid) and bacteriophage treatment was determined for a single treatment, successive treatment, and prophylaxis. Both models showed a reduction in bacterial load after a single bacteriophage treatment. Increasing the frequency
SUBMITTER: Molendijk MM
PROVIDER: S-EPMC11373223 | biostudies-literature | 2024 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA